» Articles » PMID: 15531916

Ron Tyrosine Kinase Receptor Regulates Papilloma Growth and Malignant Conversion in a Murine Model of Skin Carcinogenesis

Overview
Journal Oncogene
Date 2004 Nov 9
PMID 15531916
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Recent studies demonstrate that the receptor tyrosine kinase (TK) Ron is tumorigenic when overexpressed and plays a role in regulating skin homeostasis. We hypothesized that Ron signaling promotes skin carcinogenesis. To test this hypothesis, mice deficient in the TK domain of Ron (TK(-/-) mice) were crossed with v-Ha-ras (Tg.AC) transgenic mice; the resulting TK(-/-) Tg.AC(+/-) mice, and their controls, were utilized in a model of chemically induced Ras-mediated skin carcinogenesis. The mice were treated with 2.5 microg of 12-O-tetradecanoylphorbol-13-acetate applied weekly to the shaved back of 36 control (TK(+/+) Tg.AC(+/-)) and 35 experimental (TK(-/-) Tg.AC(+/-)) mice. In an analysis of the resulting papillomas, a reduction in cellular proliferation and papilloma volume was found in the TK(-/-) Tg.AC(+/-) mice compared to controls. Further, Ron protein expression was upregulated during papilloma formation. Ablation of Ron signaling resulted in partial defects in MAPK and Akt signaling that may account for the decreased papilloma growth in the TK(-/-) Tg.AC(+/-) mice. The papilloma-bearing mice were monitored for the occurrence of malignant skin tumors and other malignant tumor types for a period of 48 weeks. Loss of Ron receptor signaling significantly reduced the percent of papillomas that underwent malignant conversion as well as the number of mice developing other malignant tumor types. In conclusion, these studies demonstrate that Ron signaling augments papilloma growth and malignant conversion in vivo.

Citing Articles

Regulation of Macrophage Polarization by RON Receptor Tyrosine Kinase Signaling.

Chaudhuri A Front Immunol. 2014; 5:546.

PMID: 25400637 PMC: 4215628. DOI: 10.3389/fimmu.2014.00546.


Host genetic background impacts modulation of the TLR4 pathway by RON in tissue-associated macrophages.

Chaudhuri A, Wilson N, Yang B, Martinez A, Liu J, Zhu C Immunol Cell Biol. 2013; 91(7):451-60.

PMID: 23817579 PMC: 3736205. DOI: 10.1038/icb.2013.27.


Ron tyrosine kinase receptor synergises with EGFR to confer adverse features in head and neck squamous cell carcinoma.

Keller J, Nimnual A, Shroyer K, Joy C, Ischenko I, Chandler C Br J Cancer. 2013; 109(2):482-92.

PMID: 23799848 PMC: 3721396. DOI: 10.1038/bjc.2013.321.


MSP-RON signalling in cancer: pathogenesis and therapeutic potential.

Yao H, Zhou Y, Zhang R, Wang M Nat Rev Cancer. 2013; 13(7):466-81.

PMID: 23792360 DOI: 10.1038/nrc3545.


Distinct involvement of the Gab1 and Grb2 adaptor proteins in signal transduction by the related receptor tyrosine kinases RON and MET.

Chaudhuri A, Xie M, Yang B, Mahapatra K, Liu J, Marsters S J Biol Chem. 2011; 286(37):32762-74.

PMID: 21784853 PMC: 3173233. DOI: 10.1074/jbc.M111.239384.